Entecavir monotherapy is effective in suppressing hepatitis b virus after liver transplantation

Gastroenterology

Volumn 141, Issue 4, 2011, Pages 1212-1219

  Fung, James ^a   Cheung, Cindy ^b   Chan, Seeching ^a,b   Yuen, Manfung ^a   Chok, Kenneth S H ^a   Sharr, William ^a   Dai, Wingchiu ^a   Chan, Albert C Y ^a   Cheung, Tanto ^a   Tsang, Simon ^a   Lam, Banny ^a   Lai, Chinglung ^a   Lo, Chungmau ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Liver Disease; Outcomes; Prevention; Recurrence

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ABSENCE OF SIDE EFFECTS; ACUTE CORONARY SYNDROME; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER EPIDEMIOLOGY; DECOMPENSATED LIVER CIRRHOSIS; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 80053583302     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.083     Document Type: Article

References (38)

1. C.L. Lai, V. Ratziu, and M.F. Yuen Viral hepatitis B Lancet 362 2003 2089 2094 (Pubitemid 38032767)
2. W. Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745 (Pubitemid 27527771)
3. S. Todo, A.J. Demetris, and D. Van Thiel Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 1991 619 626
4. J.G. O'Grady, H.M. Smith, and S.E. Davies Hepatitis B virus reinfection after orthotopic liver transplantation Serological and clinical implications J Hepatol 14 1992 104 111
5. P.J. Johnson, M.H. Wansbrough-Jones, and B. Portmann Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin Br Med J 1 1978 216 (Pubitemid 8273426)
6. J. Gugenheim, E. Baldini, and D. Ouzan Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation Transplant Proc 29 1997 517 518 (Pubitemid 27123514)
7. R.W. McGory, M.B. Ishitani, and W.M. Oliveira Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization Transplantation 61 1996 1358 1364 (Pubitemid 26152826)
8. D. Samuel, A. Bismuth, and D. Mathieu Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients Lancet 337 1991 813 815
9. H.P. Lemmens, J.M. Langrehr, and G. Blumhardt Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis Transplant Proc 26 1994 3622 3623
10. N.A. Terrault, S. Zhou, and C. Combs Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 24 1996 1327 1333 (Pubitemid 26399024)
11. C.L. Lai, R.N. Chien, N.W. Leung Asia Hepatitis Lamivudine Study Group A one-year trial of lamivudine for chronic hepatitis B N Engl J Med 339 1998 61 68 (Pubitemid 28304879)
12. R.P. Perrillo, T. Wright, and J. Rakela A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B Hepatology 33 2001 424 432 (Pubitemid 32119032)
13. C.M. Lo, S.T. Cheung, and C.L. Lai Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis Ann Surg 233 2001 276 281
14. D. Mutimer, G. Dusheiko, and C. Barrett Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up Transplantation 70 2000 809 815
15. C.M. Lo, J.T. Fung, and G.K. Lau Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B Hepatology 37 2003 36 43 (Pubitemid 36042142)
16. J.S. Markowitz, P. Martin, and A.J. Conrad Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin Hepatology 28 1998 585 589 (Pubitemid 28363690)
17. M.L. Yan, L.N. Yan, and B. Li Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation Hepatobiliary Pancreat Dis Int 5 2006 360 363 (Pubitemid 44295187)
18. J. Rosenau, M.J. Bahr, and H.L. Tillmann Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection J Hepatol 34 2001 895 902 (Pubitemid 32595190)
19. P.W. Angus, G.W. McCaughan, and E.J. Gane Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B Liver Transpl 6 2000 429 433 (Pubitemid 30489114)
20. G. Ferretti, M. Merli, and S. Ginanni Corradini Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation Transplant Proc 36 2004 535 538 (Pubitemid 38534313)
21. Z. Karasu, T. Ozacar, and M. Akyildiz Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation Antivir Ther 9 2004 921 927 (Pubitemid 40040266)
22. E.J. Gane, P.W. Angus, and S. Strasser Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation Gastroenterology 132 2007 931 937 (Pubitemid 46440868)
23. J. Dumortier, P. Chevallier, and J.Y. Scoazec Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results Am J Transplant 3 2003 999 1002 (Pubitemid 36917547)
24. A. Marzano, M. Salizzoni, and W. Debernardi-Venon Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis J Hepatol 34 2001 903 910 (Pubitemid 32595191)
25. R. Loomba, A.K. Rowley, and R. Wesley Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis Clin Gastroenterol Hepatol 6 2008 696 700
26. W. Rao, X. Wu, and D. Xiu Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis Transpl Int 22 2009 387 394
27. L.H. Katz, M. Paul, and D.G. Guy Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis Transpl Infect Dis 12 2010 292 308
28. M. Yuen, W. Seto, and D. Chow Long-term beneficial outcome of Chinese asymptomatic patients with HBeAg-positive chronic hepatitis B on continuous lamivudine therapy: 7-year experience Hepatology 42 2005 583A
29. C.L. Lai, M. Rosmawati, and J. Lao Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection Gastroenterology 123 2002 1831 1838 (Pubitemid 35408307)
30. D.J. Tenney, S.M. Levine, and R.E. Rose Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine Antimicrob Agents Chemother 48 2004 3498 3507 (Pubitemid 39129351)
31. D.J. Tenney, R.E. Rose, and C.J. Baldick Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy Hepatology 49 2009 1503 1514
32. P.W. Angus, S.J. Patterson, and S.I. Strasser A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis Hepatology 48 2008 1460 1466
33. Z.F. Xi, Q. Xia, and J.J. Zhang The role of entecavir in preventing hepatitis B recurrence after liver transplantation J Dig Dis 10 2009 321 327
34. M. Jimenez-Perez, A.B. Saez-Gomez, and L. Mongil Poce Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant Transplant Proc 42 2010 3167 3168
35. C.M. Lo, C.L. Liu, and S.C. Chan Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B J Hepatol 43 2005 283 287
36. C.M. Lo, G.K. Lau, and S.C. Chan Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B Am J Transplant 7 2007 434 439 (Pubitemid 46096337)
37. W. Petry, O. Adams, and D. Haussinger Fatal hepatitis B reinfection after orthotopic liver transplantation in an HBsAg negative patient following withdrawal of lamivudine J Hepatol 33 2000 514 515 (Pubitemid 30663393)
38. C.S. Coffin, P.M. Mulrooney-Cousins, and G. van Marle Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy Liver Transpl 17 2011 955 962